News

ITEK

Rocket Pharmaceuticals To Gain Nasdaq Listing via Inotek Merger

Edward Kim | Equities.com |

Pipeline of rare disease candidates based on gene therapy (Image: Medical News Today).


Sponsored Financial Content

Market Movers